Nyxoah S.A. ( NYXH) - Stock Earnings
NYXH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
NYXH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -27.7 million USD | 2.3 million USD |
| 2025Q4 | -27.6 million USD | 6.6 million USD |
| 2026Q1 | -21.1 million USD | 8.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NYXH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -47.8 million USD | 4.8 million USD |
| 2024 | -61.7 million USD | 4.7 million USD |
| 2025 | -105.8 million USD | 11.8 million USD |
| 2026 Est. | — | — |
NYXH
Price: $1.54
52 week price:
Earnings Per Share: -2.50 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Belgium
Volume: 11600
Market Capitalization: 68.1 million